CellSeed Inc
TSE:7776

Watchlist Manager
CellSeed Inc Logo
CellSeed Inc
TSE:7776
Watchlist
Price: 489 JPY -0.41% Market Closed
Market Cap: 16.9B JPY
Have any thoughts about
CellSeed Inc?
Write Note

P/E
Price to Earnings

-17.1
Current
-9.2
Median
23
Industry
Lower than median
Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
-17.1
=
Market Cap
16.4B JPY
/
Net Income
-957m JPY
All Countries
Close
Market Cap P/E
JP
CellSeed Inc
TSE:7776
16.4B JPY -17.1
FR
Pharnext SCA
OTC:PNEXF
6T USD -177 666.1
US
Abbvie Inc
NYSE:ABBV
302.3B USD 59.5
US
Amgen Inc
NASDAQ:AMGN
160.6B USD 38
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
126.3B USD -263.2
US
Gilead Sciences Inc
NASDAQ:GILD
118.3B USD 939
US
Epizyme Inc
F:EPE
94.1B EUR -480.9
AU
CSL Ltd
ASX:CSL
138.5B AUD 34.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
90.4B USD 19.4
US
Seagen Inc
F:SGT
39.3B EUR -55.7
NL
argenx SE
XBRU:ARGX
33.4B EUR -127.9
Earnings Growth
JP
CellSeed Inc
TSE:7776
Average P/E: 218
Negative Multiple: -17.1
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -177 666.1 N/A
US
Abbvie Inc
NYSE:ABBV
59.5
412%
US
Amgen Inc
NASDAQ:AMGN
38
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -263.2
42%
US
Gilead Sciences Inc
NASDAQ:GILD
939
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -480.9 N/A
AU
CSL Ltd
ASX:CSL
34.3
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.4
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -55.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -127.9 N/A

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
N/A
2-Years Forward
P/E
N/A
3-Years Forward
P/E
N/A

See Also

Discover More